
Blood glucose fluctuations impair bone defect repair in Type 2 Diabetes (T2DM). A novel approach demonstrated the efficacy of a hydrogel delivery system (Exos-Smpd3@Ns) combining Smpd3-overexpressing exosomes and nanosilver ions. This system improved osteogenic differentiation and jawbone regeneration under glucose-fluctuating conditions. Mechanistically, Smpd3 activated autophagy in jawbone-derived BMSCs while reducing macrophage polarization and oxidative stress. In vitro studies confirmed enhanced osteogenesis and differentiation of BMSCs, as well as jawbone regeneration in diabetic dogs. This work highlights the therapeutic potential of Smpd3 and its exosome delivery system in addressing bone regeneration disorders in T2DM patients, offering a promising strategy for clinical application.
Like
Save
Share